HER2-reactive T cells were enumerated by IFN-γ ELISpot assay (BD Biosciences)(21 (link)). PBL or SC were incubated with recombinant HER2 or Neu protein (ecd-Fc fusion; Sino Biological). Results were expressed as spot forming units per 106 SC and analyzed using student’s t test.
Quantification of HER2-Specific Immunity
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : The Barbara Ann Karmanos Cancer Institute, Wayne State University, University of Arizona, National Cancer Institute, Center for Cancer Research, Moffitt Cancer Center
Variable analysis
- Immunization
- HER2 IgG levels measured by binding to HER2+ SKOV3 cells using flow cytometry
- HER2-reactive T cells enumerated by IFN-γ ELISpot assay
- Time point (2 weeks following the last immunization)
- MAb TA-1 standard used for HER2 IgG measurement
- Normal mouse serum
- Isotype matched mAb
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!